Laser therapy is an effective treatment for onychomycosis. It uses a wavelength of light that can penetrate the nail and the surrounding tissue without harming it.
Currently, available treatments for onychomycosis include topical antifungal nail paints and oral antifungal medications such as itraconazole and terbinafine. These medications have low efficacy and require a long course of treatment.
Benefits
The Lunula laser system is a safe and effective treatment for onychomycosis. Unlike topical treatments that can only reach the surface of the nail, laser therapy can penetrate deeper into the nail bed and kill the fungus. It is also pain-free and requires no downtime. This non-invasive procedure has been shown to improve the appearance of brittle, thickened, and discolored nails. It can even reverse the growth of fungus in as little as three to six months.
Fungal nails are a common condition affecting millions of people worldwide. These infections can be difficult to treat with traditional antifungal agents such as topical nail lacquers and oral medications. However, these medications have numerous drawbacks, including poor tolerability, a high rate of relapse, and potential hepatotoxicity.
A systematic review and meta-analysis of existing literature has reported favorable outcomes for the use of laser therapy to treat onychomycosis compared with traditional treatments. The studies included randomized controlled trials (RCTs) and nonrandomized comparative studies with no control group. Most studies used a PICO approach to identify relevant outcomes, including symptoms, change in disease status, medication use, and treatment-related morbidity. However, the studies had methodologic limitations, such as a lack of blinding, reporting on an individual nail basis rather than an overall population, and an inability to compare relapse rates between groups.
In addition to directly killing the fungus, laser treatment stimulates the immune response and increases blood flow to the affected nails, which allows for better absorption of antifungal medication. Patients with severe onychomycosis may benefit from multiple treatment sessions spaced several weeks apart.
The efficacy of laser therapy for onychomycosis has been demonstrated in a number of small trials, which were published in peer-reviewed journals and analyzed using the preferred reporting items for systematic reviews and meta-analysis (PRISMA). These studies showed that laser treatment is comparable to conventional medications such as terbinafine, with the additional benefits of being noninvasive and avoiding potential hepatotoxicity.
Although the results of these trials are promising, further large-scale randomized controlled trials are needed to establish laser treatment as a standard practice. These studies should address the primary outcomes of symptom relief and mycologic cure, as well as the secondary outcomes of clinical improvement and tolerability.
Safety
Lasers can be used to kill the fungus that causes onychomycosis. The lasers work by penetrating the nail plate and destroying the fungal cells. They can also stimulate the immune system, helping the body fight the infection. The lasers are not harmful to the surrounding tissue and do not cause pain or discomfort. They also do not have side effects like those associated with oral antifungal medication.
The effectiveness of laser treatment for onychomycosis is well documented in a number of clinical trials. However, the quality of these studies is poor, and the results are often inconsistent. Most of the trials have low clinical and mycological cure rates, and only a few had blinded assessment of outcomes. The length of follow-up in the majority of the trials is also not sufficient to determine recurrence rates.
A recent meta-analysis found that a variety of laser treatments can effectively cure onychomycosis. The study examined a total of 16 RCTs that analyzed mycological cure, KOH tests, and clinical improvement assessed by blinded investigators. The chi-squared test was used to identify heterogeneity in the data. When significant heterogeneity was present, a random effects model was used.
The Lunula laser is an FDA-cleared device that uses a wavelength of light to treat onychomycosis. It delivers deep, pulse-profile heating that kills the parasitic fungus and stimulates the natural growth and immune response of the nails. This makes it an ideal option for patients who are not suitable candidates for oral antifungal medications. Unlike topical medications, the Lunula laser is non-invasive and requires no downtime. It also provides effective results, with noticeable improvements in the appearance of the nails over time. Typically, multiple laser sessions are needed to achieve the desired results. These sessions are spaced several weeks apart.
Side Effects
Laser therapy is painless and safe, with only a warming or tingling sensation felt by the patient during treatment. It is also non-invasive and requires no medication to be taken orally. Some patients may experience scabbing or minor bleeding after the procedure, but these effects typically resolve on their own without further care. Laser treatment for nail fungus is not a substitute for oral antifungal medications, but it can be used in conjunction with these treatments to improve outcomes.
The evidence supporting the efficacy of laser therapy for onychomycosis is based primarily on a few RCT studies, as well as other types of research. These studies have significant methodological limitations, such as small sample sizes, lack of blinding of the outcome assessment and inconsistencies in measuring the results. Despite these issues, the findings of these studies are generally favorable. In one meta-analysis, the mycological efficacy of a continuous itraconazole pulse treatment and laser therapy were found to be similar.
Unlike oral antifungal medications, which can cause serious side effects including liver and kidney toxicity, laser therapy is not associated with such side effects. Additionally, laser treatment is more effective than topical antifungal creams, which can only be applied to the surface of the nail and do not penetrate the underlying infection.
Researchers have developed different laser systems that are specifically designed to target the fungus in the toenails. These systems use a variety of wavelengths to attack the pathogen from different angles. For example, the 405 nm (violet laser) can be used to target the fungus and break down its cellular structure by disrupting the mitochondria. This allows the toenail’s immune system to eradicate the fungus more effectively.
The Lunula Laser is a FDA-cleared device that uses laser light to stimulate the nail’s cellular and immune responses, helping the body fight the fungus from within. This system also combines the laser with a topical antifungal agent to enhance the treatment’s effectiveness. Some clinics also incorporate oral antifungal medications alongside laser sessions for more severe infections if the patient is a candidate for these drugs.
Cost
Fungal nail infections (onychomycosis) are a common and difficult-to-treat dermatological condition. They typically start as a white or yellow spot under the nail and progress to brittle, thickened nails over time. Traditionally, the condition has been treated with topical antifungal creams or oral medications, which are not always effective and can have unpleasant side effects. The Lunula Laser, an FDA-cleared device, provides a safe, painless and non-invasive treatment that can help patients regain healthy, fungus-free nails.
A meta-analysis of 12 published studies (one RCT and 11 case series) found that laser treatment significantly improves nail appearance and mycological cure rates compared to traditional treatments. The majority of studies utilized neodymium-doped yttrium aluminum garnet (Nd:YAG) lasers that operate at 1064 nm. Other systems, such as diode and Q-switched lasers, operate at near-infrared wavelengths with nanosecond pulse durations that do not damage surrounding tissues.
The Lunula Laser uses a combination of wavelengths that work together to treat onychomycosis. The 635 nm diode produces Nitric Oxide and the 405 nm diode generates Reactive Oxygen Species, both of which have powerful anti-microbial properties. The combination of these two technologies allows the laser to target the infection in the nail and nail bed, while simultaneously stimulating the body’s natural healing response.
This low-level laser therapy has been in clinical use since 2007, and has shown consistent results in clinical trials. It is also safe, non-invasive and requires a minimum of three weekly 12 minute sessions. Patients should experience a slight warming sensation during the treatment, but there is no pain or discomfort.
The cost of the Lunula laser is likely to be covered by health insurance, but coverage will depend on your provider’s plan and coverage language. The procedure is considered reconstructive and will likely be coded under CPT 17999 (Unlisted procedures, skin, mucous membrane and subcutaneous tissue). Patients interested in pursuing laser treatment for onychomycosis should discuss their insurance options with their provider. The best way to avoid the potential costs associated with this procedure is to start treatment early. The earlier you begin, the fewer treatments you will need and the less expensive it will be to get clear nails.